What Drove BBWI's Raised Guidance After a Strong Q2 Performance?

Bath & Body Works (BBWI) reported robust Q2 FY2025 results, with net sales reaching $1.5 billion and adjusted EPS of 37 cents, both at the high end of management's prior guidance, driven by strong performance during key sales periods. Consequently, the company raised its full-year adjusted EPS outlook to $3.35-$3.60 and narrowed its sales growth forecast to 1.5-2.7%. Despite anticipating an $85 million tariff impact, management expressed confidence in mitigating these costs through its U.S.-based supply chain, while also increasing its share repurchase plan to $400 million, signaling strong cash generation and commitment to shareholder returns amidst ongoing strategic investments.

Analysis

Bath & Body Works delivered a strong second-quarter fiscal 2025, with net sales growing 1.5% year-over-year to $1.5 billion and an adjusted EPS of 37 cents, both metrics reaching the high end of prior guidance. This outperformance, attributed to a successful semiannual sale and new product launches, prompted management to raise its full-year adjusted EPS forecast to a range of $3.35-$3.60, lifting the low end from $3.25. Despite this operational strength and a forecasted gross profit rate of approximately 44%, the company faces a material headwind from an $85 million annual tariff impact, with $40 million concentrated in the third quarter. Management has signaled confidence in mitigating these costs via its vertically integrated, U.S.-based supply chain. This confidence is further demonstrated by an increased share repurchase authorization to $400 million. A notable disconnect exists between these positive fundamentals and market valuation; the stock has declined 5.9% over the past three months against an 18.3% industry gain and trades at a forward price-to-sales ratio of 0.71x, significantly below the 1.96x industry average.

Key Decisions for Investors

• Investors should consider the potential value opportunity presented by the stock's significant valuation discount and recent underperformance relative to the industry, especially in light of the company's raised EPS guidance and operational execution.
• The primary risk to monitor is management's ability to successfully mitigate the $85 million tariff impact; gross margin performance in the upcoming quarters will be a critical indicator of the U.S.-based supply chain's resilience.
• The increased $400 million share repurchase authorization should be viewed as a strong signal of management's confidence in future cash flow and the attractiveness of the current share price, potentially providing a floor for the stock.